Related Experiment Video
Updated: Jun 7, 2026
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.9K
Glioblastoma in Patients With Multiple Sclerosis
Jillian M Berkman1, Vihang Nakhate1, L Nicolas Gonzalez Castro2
1Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
The Neurohospitalist
|September 23, 2022
Summary
This study investigated the rare co-occurrence of multiple sclerosis (MS) and glioma. Findings suggest chronic demyelination does not directly lead to glioma development, offering insights for managing these complex cases.
Area of Science:
- Neuro-oncology
- Neurology
- Demyelinating Diseases
Background:
- Co-occurrence of multiple sclerosis (MS) and glioma presents diagnostic and management challenges.
- Rare cases require careful consideration for neurologists and neuro-oncologists.
Purpose of the Study:
- To report on a cohort of patients with both MS and glioma.
- To investigate the relationship between demyelination and gliomagenesis.
- To provide management recommendations for concurrent conditions.
Main Methods:
- Single-center cohort study.
- Analysis of four patients diagnosed with multiple sclerosis who subsequently developed gliomas.
- Review of epidemiological data for glioma subtypes (IDH-wildtype and IDH-mutant).
Main Results:
- The patient cohort's glioma epidemiology mirrored general trends (IDH-wildtype and IDH-mutant).
- In most cases (3/4), gliomas did not arise in areas of pre-existing demyelinating lesions.
- No evidence supported chronic gliosis from demyelination as a direct precursor to glioma.
Conclusions:
- Chronic demyelination is unlikely to be a direct substrate for secondary glioma induction.
- Recommendations are provided for differentiating neoplastic from demyelinating lesions.
- Key considerations for managing patients with both MS and glioma are highlighted.
